BASE LABORATORIES CORNEAL FLOW HYPERTONICITY OPHTHALMIC EYE- sodium chloride ointment 
Joonem LLC

----------

Base Laboratories Corneal Flow Hypertonicity Ophthalmic Eye Ointment

Drug Facts

Active ingredient

Sodium chloride 3%

Purpose

Hypertonicity agent

Uses:

Temporary relief of corneal edema

Warnings:

For external use only

Do not use

Except under the advice and supervision of a doctor

When using this product

  • It may cause temporary burning and irritation 
  • Replace cap after use
  • To avoid contamination, do not touch top of container to any surface

Stop use and ask a doctor if 

  • Condition worsens or persists for more than 72 hours
  • You experience eye pain, changes in vision, continued redness or irritation of the eye

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

  • Pull down the lower lid of the affected eye
  • Apply a small amount (1/4 inch) of ointment to the inside of eyelid
  • Apply every 3 to 4 hours or as directed by a doctor

Other information

  • Store at 15-25C (59-77F)
  • Keep tightly closed
  • Do not Freeze
  • Do not use if difficult to dispense or visible particles are seen in the product
  • Side effects associated with this product may be reported to the email address below

Inactive ingredients

Water, Glycerin, Propylene Glycol, Squalane, Sodium Hyaluronate, Dimethicone, Tocopheryl Acetate, Carnosine, Butylene Glycol, Phenoxyethanol, Chlorphenesin, Ubiquinone

Questions or comments?

cs@baselaboratories.com

Package Labeling:

Label0

BASE LABORATORIES CORNEAL FLOW HYPERTONICITY OPHTHALMIC EYE 
sodium chloride ointment
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:80327-011
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X) (CHLORIDE ION - UNII:Q32ZN48698) SODIUM CHLORIDE30 mg  in 1 g
Inactive Ingredients
Ingredient NameStrength
WATER (UNII: 059QF0KO0R)  
GLYCERIN (UNII: PDC6A3C0OX)  
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
SQUALANE (UNII: GW89575KF9)  
HYALURONATE SODIUM (UNII: YSE9PPT4TH)  
DIMETHICONE (UNII: 92RU3N3Y1O)  
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)  
CARNOSINE (UNII: 8HO6PVN24W)  
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
PHENOXYETHANOL (UNII: HIE492ZZ3T)  
CHLORPHENESIN (UNII: I670DAL4SZ)  
UBIDECARENONE (UNII: EJ27X76M46)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:80327-011-003 in 1 CARTON01/01/202312/31/2023
15 g in 1 TUBE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM01801/01/202312/31/2023
Labeler - Joonem LLC (117633878)

Revised: 11/2024
Document Id: 27dc2889-79cf-8a37-e063-6394a90aeee2
Set id: d44e8198-8ba1-46ee-be88-0228368b7640
Version: 4
Effective Time: 20241126
 
Joonem LLC